Pathologies and Treatments

Presbyopia

Presbyopia, commonly known as farsightedness or age-related near vision loss, is the progressive loss of accommodation. This results in difficulty seeing nearby objects clearly. It affects all individuals starting around the age of 40–50. It is usually corrected with reading glasses or with progressive glasses or contact lenses.

Presbyopia is caused by the loss of elasticity in the crystalline lens. The crystalline lens is the eye’s natural lens, located between the cornea and the retina. It has the ability to accommodate—that is, to focus on objects depending on their distance. However, with age, it loses elasticity and focusing ability, which leads to presbyopia.

Symptoms

Presbyopia causes difficulty focusing on nearby images, which initially results in a sensation of blurred vision while reading, and as it progresses, leads to difficulty seeing at intermediate distances as well.

Treatments

Presbyopia surgery includes various techniques depending on age, required prescription, and the specific characteristics of the eye. Each case is evaluated through a series of tests that allow us to determine the most appropriate technique for each patient.

Although there are many projects in development to treat presbyopia, currently the only definitive treatment to correct it involves removing the crystalline lens, which—due to the age-related loss of accommodation—is the cause of presbyopia. The lens is replaced with a monofocal lens (in monovision), an EDOF lens, or a trifocal lens.

Among all current techniques used to correct presbyopia, at the Institut de la Màcula we recommend removing the clear crystalline lens and implanting an intraocular lens (EDOF/trifocal/monofocal in monovision), as these are the safest, most stable, effective, and definitive methods.

At the Institut de la Màcula, we select the most suitable type of lens based on the eye’s characteristics and each person’s visual needs, according to their preferences, activities, or profession.

Medicina regenerativa: Endoret

Con el tratamiento de medicina regenerativa Endoret propiciamos la reparación de la superficie ocular afectada por la sequedad ocular. Se trata de un plasma rico en factores de crecimiento para el tratamiento de las lesiones de la superficie ocular elaborado a partir de la sangre del mismo paciente. Con esta formulación individualizada se consigue una tolerancia completa y una efectividad óptima. Esta opción terapéutica revolucionaria es muy eficaz en casos de defectos epiteliales persistentes o úlceras corneales. Asimismo se puede aplicar después de una cirugía refractiva corneal, una cirugía ocular o en el Síndrome de Sjögren.

Pathologies and Treatments

Presbyopia

Symptoms

Treatments

Medicina regenerativa: Endoret

Procedures

Medicina regenerativa: Endoret

Dra. Paula Verdaguer,

MD, PhD

Número de Col·legiat COMB: 40737

Ophthalmologist. Specialist in Cornea, Refractive Surgery, and Cataracts

SCHEDULE

WE CALL YOU